Search for: [Abstract = "ogically verified dysplasia and neoplastic lesions. 54. \( 60,67%\) lesions were identified using standard cystoscopy . There were \: 2 \(2,24%\) – dysplasias, 18 tumours \(20,22%\) –TaG1, 6 tumours \(6,74%\) – TaG2, 16 neoplastic lesions \(17,97%\) – T1G1, 8 tumours \( 8,98%\) – T1G2 and 4 neoplastic lesions \(4,49%\) – T1G3. All lesions seen using white light cystoscopy was also seen in fluorescence cystoscopy. 35 \(39,33%\) lesions were identified using only HAL fluorescence cystoscopy. There were\: 19\(21,34%\) dysplasias, 4 tumours \(4,49%\) – TaG1, 3 tumours \(3,37%\) – TaG2, 2 tumours \(2,24%\) – T1G1, 2 tumours \( 2,24%\) – T1G2, 2 neoplastic lesions \(2,24%\) – T1G3 and 3 carcinoma in situ \- Cis \( 3,37%\) . Analyzing the false\-positive results. The false detection rate is the number of suspected lesions per technique that had negative histology divided by the total number of areas biopsied with that technique. The mean false\-positive rate on biopsy for HAL was 41,66% compared with 25% for standard cystoscopy. It was analyzed the recurrence rate – RR. RR = number of recurrences\/ number of months in observation x 100%. The mean recurrence rate in patients on TURBT in white light cystoskopy was 0,093 recurrence\/month\/patient and the mean recurrence rate in patients on TURBT in PDD was 0,073 recurrence\/month\/patient. Conclusions\: 1.Fluorescence cystoscopy improves the detection of ne"]

Number of results: 1